Immutep Limited (YP1A) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.086x

Based on the latest financial reports, Immutep Limited (YP1A) has a cash flow conversion efficiency ratio of -0.086x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-11.72 Million ≈ $-13.70 Million USD) by net assets (€136.47 Million ≈ $159.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Immutep Limited for the company's overall valuation and market capitalisation.

Immutep Limited - Cash Flow Conversion Efficiency Trend (2017–2023)

This chart illustrates how Immutep Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Immutep Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Immutep Limited ranked by their cash flow conversion efficiency. See cash flow to debt ratio of Immutep Limited to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Donaco International Ltd AU:DNA	0.032x
Havanna Holding SA BA:HAVA	0.080x
Shanghai Supezet Engineering Technology Corp Ltd SHG:688121	-0.016x
The Generation Essentials Group NYSE:TGE	-0.002x
Orge Enerji Elektrik Taahhut AS IS:ORGE	-0.032x
VerticalScope Holdings Inc TO:FORA	0.048x
WinVest Acquisition Corp NASDAQ:WINV	0.029x
Korea Computer Inc KQ:054040	0.048x

Annual Cash Flow Conversion Efficiency for Immutep Limited (2017–2023)

The table below shows the annual cash flow conversion efficiency of Immutep Limited from 2017 to 2023. View today's stock price for Immutep Limited for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-06-30	€136.47 Million ≈ $159.55 Million	€-35.36 Million ≈ $-41.33 Million	-0.259x	-17.20%
2022-06-30	€136.76 Million ≈ $159.88 Million	€-30.23 Million ≈ $-35.34 Million	-0.221x	+8.19%
2021-06-30	€73.27 Million ≈ $85.66 Million	€-17.64 Million ≈ $-20.62 Million	-0.241x	+26.04%
2020-06-30	€33.30 Million ≈ $38.93 Million	€-10.84 Million ≈ $-12.67 Million	-0.326x	+48.07%
2019-06-30	€24.39 Million ≈ $28.51 Million	€-15.29 Million ≈ $-17.87 Million	-0.627x	-170.19%
2018-06-30	€33.52 Million ≈ $39.19 Million	€-7.78 Million ≈ $-9.09 Million	-0.232x	+27.64%
2017-06-30	€26.53 Million ≈ $31.02 Million	€-8.51 Million ≈ $-9.95 Million	-0.321x	--

About Immutep Limited

F:YP1A Germany Biotechnology

Market Cap

$39.28 Million

€33.60 Million EUR

Market Cap Rank

#22890 Global

#2002 in Germany

Share Price

€0.23

Change (1 day)

-14.29%

52-Week Range

€0.23 - €2.64

All Time High

€4.52